Table 2.

Results from the CPCRA study

	Model 1			Model 2
Variable	Est	SE	p-value	Est	SE	p-value
	Longitudinal
Intercept	4.07	0.18	<0.0001	4.06	0.18	<0.0001
Treatment	−0.08	0.11	0.47	−0.08	0.11	0.49
Year	−0.79	0.10	<0.0001	−0.77	0.11	<0.0001
Gender	0.24	0.19	0.20	0.25	0.19	0.19
PrevOI	−0.95	0.14	<0.0001	−0.94	0.14	<0.0001
Stratum	0.12	0.13	0.38	0.13	0.13	0.34
HgB	0.23	0.03	<0.0001	0.24	0.03	<0.0001
Treatment × Year	−0.09	0.12	0.45	−0.10	0.12	0.43
Random Effect: Intercept	1.21	0.09	<0.0001	1.22	0.09	<0.0001
Random Effect: Slope	0.67	0.11	<0.0001	0.66	0.11	<0.0001
Random Effect Covariance	−0.03	0.07	0.73	−0.02	0.07	0.77
$\sigma \frac{2}{e}$	0.30	0.01	<0.0001	0.30	0.01	<0.0001
	Survival
Treatment	−0.26	0.19	0.17	−0.28	0.18	0.14
CD4	0.36	0.19	0.06	0.32	0.21	0.12
Shared Effect Intercept	−0.92	0.24	0.0001	−0.71	0.31	0.02
Shared Effect Slope	−0.75	0.30	0.01	−0.90	0.39	0.02
CD4×Shared Effect Intercept	NA	NA	NA	−0.06	0.06	0.29
CD4×Shared Effect Slope	NA	NA	NA	0.09	0.09	0.33
Gender	−0.19	0.32	0.55	−0.16	0.31	0.62
PrevOI	1.47	0.36	<0.0001	1.37	0.35	0.0001
Stratum	−0.18	0.21	0.41	−0.20	0.21	0.34
HgB	−0.50	0.08	<0.0001	−0.49	0.09	<0.0001